title: In reply.
authors: Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina California Maternal Quality Care Collaborative, Stanford, California, California Pacific Medical Center, San Francisco, California The American College of Obstetricians and Gynecologists, Washington, DC.
authors: M Kathryn
authors: MK
authors: Menard
authors: Elliot K
authors: EK
authors: Main
authors: Sean M
authors: SM
authors: Currigan
mesh_terms: D000707:Anaphylaxis / Q000139:chemically induced*; D020070:Cervical Ripening / Q000187:drug effects*; D002585:Cesarean Section / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D007548:Isosorbide Dinitrate / Q000031:analogs & derivatives*; D007751:Labor, Induced; D016595:Misoprostol / Q000009:adverse effects*; D020030:Nitric Oxide Donors / Q000494:pharmacology*; D010120:Oxytocics; D011247:Pregnancy; D011273:Pregnancy, Prolonged / Q000188:drug therapy*
chemical_list: D020030:Nitric Oxide Donors; D010120:Oxytocics; D016595:Misoprostol; D007548:Isosorbide Dinitrate